© 2024 by Mares ITX GmbH.
The Advanced Technologies offered by Mares ITX is focused towards an idea of mixing a certain molecule with therapeutic cells that are injected into a single tissue or possibly into the bloodstream.
C/M - Boost is a technology that significantly increases the efficacy of Mesenchymal stem cells (MSCs) and is nothing less than a paradigm shift in stem cell therapies.
Mesenchymal stem cells are powerful adult stem cells present in multiple tissues including the umbilical cord and the bone marrow. In the recent past, Mesenchymal stem cells have gained popularity as they are used to treat vascular problems, complications regarding immunoreactions and Osteoarthritis (OA).
A large number of scientific studies have shown us that Mesenchymal stem cells are the most frequently used type of cells, primarily for producing regenerative medicine. For instance, MSC therapies help in fighting health conditions including neurological disorders, diabetes and a wide range of pathogens.
At Mares, we have identified a molecule that increases the efficacy of Mesenchymal stem cells. Based on our research, the addition of a new molecule identified by Mares ITX to MSCs before injection significantly enhances their efficacy, is not known to be toxic, and has a transient effect.
We are looking for partners who can advance our study and collaborate to make our technology market-exclusive!